nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—ABCB1—Parkinson's disease	0.588	1	CbGaD
Ezetimibe—Fluspirilene—HTR1A—Parkinson's disease	0.00234	0.14	CrCbGaD
Ezetimibe—Pimozide—DRD3—Parkinson's disease	0.00215	0.128	CrCbGaD
Ezetimibe—Fluspirilene—DRD2—Parkinson's disease	0.00199	0.119	CrCbGaD
Ezetimibe—Pimozide—HTR1A—Parkinson's disease	0.00175	0.104	CrCbGaD
Ezetimibe—Fluspirilene—HTR2A—Parkinson's disease	0.00154	0.0916	CrCbGaD
Ezetimibe—Pimozide—DRD2—Parkinson's disease	0.00149	0.0886	CrCbGaD
Ezetimibe—ANPEP—embryo—Parkinson's disease	0.00148	0.0929	CbGeAlD
Ezetimibe—Pimozide—CYP2E1—Parkinson's disease	0.00143	0.0853	CrCbGaD
Ezetimibe—SOAT1—cardiovascular system—Parkinson's disease	0.00116	0.0726	CbGeAlD
Ezetimibe—Pimozide—HTR2A—Parkinson's disease	0.00115	0.0685	CrCbGaD
Ezetimibe—Flunarizine—CYP2D6—Parkinson's disease	0.00114	0.0679	CrCbGaD
Ezetimibe—ANPEP—cardiovascular system—Parkinson's disease	0.00111	0.0695	CbGeAlD
Ezetimibe—Pimozide—CYP2D6—Parkinson's disease	0.00105	0.0626	CrCbGaD
Ezetimibe—ANPEP—medulla oblongata—Parkinson's disease	0.000946	0.0594	CbGeAlD
Ezetimibe—SOAT1—spinal cord—Parkinson's disease	0.000882	0.0553	CbGeAlD
Ezetimibe—SOAT1—head—Parkinson's disease	0.000784	0.0492	CbGeAlD
Ezetimibe—Pimozide—ABCB1—Parkinson's disease	0.00075	0.0447	CrCbGaD
Ezetimibe—ANPEP—head—Parkinson's disease	0.00075	0.047	CbGeAlD
Ezetimibe—SOAT1—nervous system—Parkinson's disease	0.000743	0.0466	CbGeAlD
Ezetimibe—SOAT1—central nervous system—Parkinson's disease	0.000715	0.0449	CbGeAlD
Ezetimibe—ANPEP—nervous system—Parkinson's disease	0.000711	0.0446	CbGeAlD
Ezetimibe—SOAT1—cerebellum—Parkinson's disease	0.000699	0.0439	CbGeAlD
Ezetimibe—ANPEP—central nervous system—Parkinson's disease	0.000684	0.0429	CbGeAlD
Ezetimibe—SOAT1—brain—Parkinson's disease	0.000568	0.0356	CbGeAlD
Ezetimibe—ANPEP—brain—Parkinson's disease	0.000543	0.0341	CbGeAlD
Ezetimibe—ABCC3—head—Parkinson's disease	0.000374	0.0234	CbGeAlD
Ezetimibe—ABCC3—nervous system—Parkinson's disease	0.000354	0.0222	CbGeAlD
Ezetimibe—ABCC3—central nervous system—Parkinson's disease	0.000341	0.0214	CbGeAlD
Ezetimibe—ABCG2—medulla oblongata—Parkinson's disease	0.000275	0.0172	CbGeAlD
Ezetimibe—ABCC3—brain—Parkinson's disease	0.000271	0.017	CbGeAlD
Ezetimibe—ABCG2—midbrain—Parkinson's disease	0.000251	0.0158	CbGeAlD
Ezetimibe—ABCG2—spinal cord—Parkinson's disease	0.000245	0.0154	CbGeAlD
Ezetimibe—ABCB1—embryo—Parkinson's disease	0.000212	0.0133	CbGeAlD
Ezetimibe—ABCG2—cerebellum—Parkinson's disease	0.000194	0.0122	CbGeAlD
Ezetimibe—ABCB1—forebrain—Parkinson's disease	0.000188	0.0118	CbGeAlD
Ezetimibe—ABCB1—cardiovascular system—Parkinson's disease	0.000159	0.00995	CbGeAlD
Ezetimibe—ABCG2—brain—Parkinson's disease	0.000158	0.0099	CbGeAlD
Ezetimibe—CYP3A4—nervous system—Parkinson's disease	0.000144	0.00902	CbGeAlD
Ezetimibe—CYP3A4—central nervous system—Parkinson's disease	0.000138	0.00869	CbGeAlD
Ezetimibe—ABCB1—medulla oblongata—Parkinson's disease	0.000135	0.0085	CbGeAlD
Ezetimibe—UGT1A3—Metabolism—DDC—Parkinson's disease	0.000134	0.000354	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CYCS—Parkinson's disease	0.000134	0.000354	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—OMD—Parkinson's disease	0.000133	0.000351	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—TALDO1—Parkinson's disease	0.000133	0.000351	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000132	0.000347	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—INS—Parkinson's disease	0.000131	0.000345	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000131	0.000344	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GCH1—Parkinson's disease	0.00013	0.000343	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000129	0.000341	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GSTA4—Parkinson's disease	0.000127	0.000335	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—DBH—Parkinson's disease	0.000127	0.000334	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—FBP1—Parkinson's disease	0.000127	0.000334	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GBA—Parkinson's disease	0.000127	0.000334	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NDUFB11—Parkinson's disease	0.000126	0.000333	CbGpPWpGaD
Ezetimibe—ABCB1—midbrain—Parkinson's disease	0.000124	0.00777	CbGeAlD
Ezetimibe—ABCB1—spinal cord—Parkinson's disease	0.000121	0.00758	CbGeAlD
Ezetimibe—ABCG2—Metabolism—GCH1—Parkinson's disease	0.000121	0.000317	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—COMT—Parkinson's disease	0.000119	0.000314	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GSTP1—Parkinson's disease	0.000118	0.000312	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—MAOA—Parkinson's disease	0.000118	0.000311	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000117	0.000309	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—HMOX1—Parkinson's disease	0.000117	0.000308	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GBA—Parkinson's disease	0.000116	0.000306	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—DBH—Parkinson's disease	0.000116	0.000306	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—FBP1—Parkinson's disease	0.000116	0.000306	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—DDC—Parkinson's disease	0.000114	0.000301	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PLA2G6—Parkinson's disease	0.000114	0.000301	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—DDC—Parkinson's disease	0.000114	0.000301	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000114	0.000299	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—MAOB—Parkinson's disease	0.000113	0.000298	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—ABCB1—Parkinson's disease	0.000112	0.000295	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000109	0.000287	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GSTM1—Parkinson's disease	0.000109	0.000287	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GSTA4—Parkinson's disease	0.000108	0.000284	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GSTA4—Parkinson's disease	0.000108	0.000284	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000108	0.000284	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—FBP1—Parkinson's disease	0.000107	0.000283	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—DBH—Parkinson's disease	0.000107	0.000283	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GBA—Parkinson's disease	0.000107	0.000283	CbGpPWpGaD
Ezetimibe—ABCB1—head—Parkinson's disease	0.000107	0.00674	CbGeAlD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000107	0.000281	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.000106	0.000278	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	0.000106	0.000278	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	0.000105	0.000278	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GPX1—Parkinson's disease	0.000104	0.000275	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.000104	0.000274	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000104	0.000273	CbGpPWpGaD
Ezetimibe—ABCB1—nervous system—Parkinson's disease	0.000102	0.00639	CbGeAlD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000101	0.000267	CbGpPWpGaD
Ezetimibe—ABCB1—central nervous system—Parkinson's disease	9.8e-05	0.00615	CbGeAlD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	9.73e-05	0.000256	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PLA2G6—Parkinson's disease	9.72e-05	0.000256	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PLA2G6—Parkinson's disease	9.72e-05	0.000256	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—MAOB—Parkinson's disease	9.63e-05	0.000254	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—MAOB—Parkinson's disease	9.63e-05	0.000254	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—MTHFR—Parkinson's disease	9.62e-05	0.000253	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	9.61e-05	0.000253	CbGpPWpGaD
Ezetimibe—ABCB1—cerebellum—Parkinson's disease	9.58e-05	0.00601	CbGeAlD
Ezetimibe—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	9.47e-05	0.00025	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	9.39e-05	0.000247	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—DDC—Parkinson's disease	9.29e-05	0.000245	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	9.24e-05	0.000243	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	9.16e-05	0.000241	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	9.01e-05	0.000237	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	9.01e-05	0.000237	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—APOE—Parkinson's disease	8.96e-05	0.000236	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	8.79e-05	0.000231	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GSTA4—Parkinson's disease	8.78e-05	0.000231	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	8.67e-05	0.000228	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	8.65e-05	0.000228	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—DDC—Parkinson's disease	8.51e-05	0.000224	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	8.46e-05	0.000223	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CYP2D6—Parkinson's disease	8.41e-05	0.000222	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CTGF—Parkinson's disease	8.26e-05	0.000218	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	8.12e-05	0.000214	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSTA4—Parkinson's disease	8.04e-05	0.000212	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	7.94e-05	0.000209	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PLA2G6—Parkinson's disease	7.9e-05	0.000208	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—DDC—Parkinson's disease	7.88e-05	0.000208	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	7.83e-05	0.000206	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—MAOB—Parkinson's disease	7.82e-05	0.000206	CbGpPWpGaD
Ezetimibe—ABCB1—brain—Parkinson's disease	7.78e-05	0.00488	CbGeAlD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	7.74e-05	0.000204	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CYP2E1—Parkinson's disease	7.69e-05	0.000203	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—TNF—Parkinson's disease	7.67e-05	0.000202	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MCCC1—Parkinson's disease	7.66e-05	0.000202	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ND3—Parkinson's disease	7.66e-05	0.000202	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—INS—Parkinson's disease	7.65e-05	0.000202	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—NQO1—Parkinson's disease	7.61e-05	0.0002	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	7.52e-05	0.000198	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—TH—Parkinson's disease	7.5e-05	0.000198	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSTA4—Parkinson's disease	7.45e-05	0.000196	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—COMT—Parkinson's disease	7.28e-05	0.000192	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	7.25e-05	0.000191	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PLA2G6—Parkinson's disease	7.24e-05	0.000191	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	7.23e-05	0.00019	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—OMD—Parkinson's disease	7.21e-05	0.00019	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—TALDO1—Parkinson's disease	7.21e-05	0.00019	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CYCS—Parkinson's disease	7.2e-05	0.00019	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	7.18e-05	0.000189	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—MAOB—Parkinson's disease	7.17e-05	0.000189	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CYP2D6—Parkinson's disease	7.15e-05	0.000188	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CYP2D6—Parkinson's disease	7.15e-05	0.000188	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	7.15e-05	0.000188	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	7.12e-05	0.000188	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CTGF—Parkinson's disease	7.02e-05	0.000185	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CTGF—Parkinson's disease	7.02e-05	0.000185	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NDUFB11—Parkinson's disease	6.83e-05	0.00018	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	6.82e-05	0.00018	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PLA2G6—Parkinson's disease	6.7e-05	0.000177	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	6.66e-05	0.000175	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—MAOB—Parkinson's disease	6.64e-05	0.000175	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	6.57e-05	0.000173	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CYP2E1—Parkinson's disease	6.54e-05	0.000172	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CYP2E1—Parkinson's disease	6.54e-05	0.000172	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GCH1—Parkinson's disease	6.52e-05	0.000172	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—NQO1—Parkinson's disease	6.47e-05	0.00017	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—NQO1—Parkinson's disease	6.47e-05	0.00017	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—COMT—Parkinson's disease	6.38e-05	0.000168	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—TH—Parkinson's disease	6.38e-05	0.000168	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—TH—Parkinson's disease	6.38e-05	0.000168	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GSTP1—Parkinson's disease	6.35e-05	0.000167	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—MAOA—Parkinson's disease	6.33e-05	0.000167	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—HMOX1—Parkinson's disease	6.26e-05	0.000165	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CYCS—Parkinson's disease	6.12e-05	0.000161	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CYCS—Parkinson's disease	6.12e-05	0.000161	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ABCB1—Parkinson's disease	6.01e-05	0.000158	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GSTM1—Parkinson's disease	5.83e-05	0.000154	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYP2D6—Parkinson's disease	5.81e-05	0.000153	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GBA—Parkinson's disease	5.81e-05	0.000153	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—DBH—Parkinson's disease	5.81e-05	0.000153	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—FBP1—Parkinson's disease	5.81e-05	0.000153	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CTGF—Parkinson's disease	5.71e-05	0.00015	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GPX1—Parkinson's disease	5.58e-05	0.000147	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—COMT—Parkinson's disease	5.42e-05	0.000143	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—COMT—Parkinson's disease	5.42e-05	0.000143	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GSTP1—Parkinson's disease	5.4e-05	0.000142	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GSTP1—Parkinson's disease	5.4e-05	0.000142	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—MAOA—Parkinson's disease	5.38e-05	0.000142	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—MAOA—Parkinson's disease	5.38e-05	0.000142	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP2D6—Parkinson's disease	5.33e-05	0.00014	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—HMOX1—Parkinson's disease	5.32e-05	0.00014	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—HMOX1—Parkinson's disease	5.32e-05	0.00014	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYP2E1—Parkinson's disease	5.32e-05	0.00014	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—NQO1—Parkinson's disease	5.26e-05	0.000138	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CTGF—Parkinson's disease	5.23e-05	0.000138	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	5.2e-05	0.000137	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—TH—Parkinson's disease	5.18e-05	0.000136	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—MTHFR—Parkinson's disease	5.15e-05	0.000136	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ABCB1—Parkinson's disease	5.11e-05	0.000135	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ABCB1—Parkinson's disease	5.11e-05	0.000135	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	5.07e-05	0.000134	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYCS—Parkinson's disease	4.97e-05	0.000131	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GSTM1—Parkinson's disease	4.96e-05	0.000131	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GSTM1—Parkinson's disease	4.96e-05	0.000131	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP2D6—Parkinson's disease	4.93e-05	0.00013	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.87e-05	0.000128	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP2E1—Parkinson's disease	4.87e-05	0.000128	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CTGF—Parkinson's disease	4.84e-05	0.000128	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—NQO1—Parkinson's disease	4.82e-05	0.000127	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—APOE—Parkinson's disease	4.8e-05	0.000126	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	4.78e-05	0.000126	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GPX1—Parkinson's disease	4.75e-05	0.000125	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GPX1—Parkinson's disease	4.75e-05	0.000125	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—TH—Parkinson's disease	4.75e-05	0.000125	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MCCC1—Parkinson's disease	4.72e-05	0.000124	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ND3—Parkinson's disease	4.72e-05	0.000124	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYCS—Parkinson's disease	4.56e-05	0.00012	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP2E1—Parkinson's disease	4.51e-05	0.000119	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NQO1—Parkinson's disease	4.46e-05	0.000118	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TALDO1—Parkinson's disease	4.44e-05	0.000117	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—OMD—Parkinson's disease	4.44e-05	0.000117	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—COMT—Parkinson's disease	4.41e-05	0.000116	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—TH—Parkinson's disease	4.4e-05	0.000116	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GSTP1—Parkinson's disease	4.38e-05	0.000116	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—MTHFR—Parkinson's disease	4.38e-05	0.000115	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—MTHFR—Parkinson's disease	4.38e-05	0.000115	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—MAOA—Parkinson's disease	4.37e-05	0.000115	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—HMOX1—Parkinson's disease	4.32e-05	0.000114	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—DDC—Parkinson's disease	4.26e-05	0.000112	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.24e-05	0.000112	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYCS—Parkinson's disease	4.22e-05	0.000111	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	4.21e-05	0.000111	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ABCB1—Parkinson's disease	4.15e-05	0.000109	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—INS—Parkinson's disease	4.1e-05	0.000108	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—APOE—Parkinson's disease	4.08e-05	0.000107	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—APOE—Parkinson's disease	4.08e-05	0.000107	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—COMT—Parkinson's disease	4.04e-05	0.000106	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GSTM1—Parkinson's disease	4.03e-05	0.000106	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTA4—Parkinson's disease	4.03e-05	0.000106	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSTP1—Parkinson's disease	4.02e-05	0.000106	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GCH1—Parkinson's disease	4.01e-05	0.000106	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—MAOA—Parkinson's disease	4.01e-05	0.000106	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—HMOX1—Parkinson's disease	3.96e-05	0.000104	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GPX1—Parkinson's disease	3.86e-05	0.000102	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ABCB1—Parkinson's disease	3.8e-05	0.0001	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	3.78e-05	9.97e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—COMT—Parkinson's disease	3.74e-05	9.85e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSTP1—Parkinson's disease	3.72e-05	9.8e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—MAOA—Parkinson's disease	3.71e-05	9.78e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSTM1—Parkinson's disease	3.69e-05	9.73e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—HMOX1—Parkinson's disease	3.67e-05	9.67e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PLA2G6—Parkinson's disease	3.62e-05	9.55e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MAOB—Parkinson's disease	3.59e-05	9.45e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—DBH—Parkinson's disease	3.58e-05	9.43e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GBA—Parkinson's disease	3.58e-05	9.43e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.58e-05	9.43e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—MTHFR—Parkinson's disease	3.56e-05	9.38e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GPX1—Parkinson's disease	3.54e-05	9.31e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ABCB1—Parkinson's disease	3.52e-05	9.28e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—INS—Parkinson's disease	3.49e-05	9.18e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—INS—Parkinson's disease	3.49e-05	9.18e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSTM1—Parkinson's disease	3.42e-05	9.01e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—APOE—Parkinson's disease	3.32e-05	8.73e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GPX1—Parkinson's disease	3.27e-05	8.62e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—MTHFR—Parkinson's disease	3.26e-05	8.6e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—APOE—Parkinson's disease	3.04e-05	8e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—MTHFR—Parkinson's disease	3.02e-05	7.96e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—INS—Parkinson's disease	2.83e-05	7.46e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—APOE—Parkinson's disease	2.81e-05	7.41e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP2D6—Parkinson's disease	2.67e-05	7.03e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—DDC—Parkinson's disease	2.63e-05	6.92e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CTGF—Parkinson's disease	2.62e-05	6.9e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—INS—Parkinson's disease	2.6e-05	6.84e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.48e-05	6.53e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP2E1—Parkinson's disease	2.44e-05	6.43e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NQO1—Parkinson's disease	2.41e-05	6.35e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—INS—Parkinson's disease	2.4e-05	6.33e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—TH—Parkinson's disease	2.38e-05	6.26e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYCS—Parkinson's disease	2.28e-05	6.01e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.23e-05	5.88e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.21e-05	5.82e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—COMT—Parkinson's disease	2.02e-05	5.32e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTP1—Parkinson's disease	2.01e-05	5.3e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MAOA—Parkinson's disease	2.01e-05	5.29e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.98e-05	5.23e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.85e-05	4.87e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GPX1—Parkinson's disease	1.77e-05	4.66e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.64e-05	4.33e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.63e-05	4.3e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.61e-05	4.25e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOE—Parkinson's disease	1.52e-05	4.01e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.5e-05	3.96e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.49e-05	3.91e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TH—Parkinson's disease	1.46e-05	3.86e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.41e-05	3.7e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—INS—Parkinson's disease	1.3e-05	3.42e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—COMT—Parkinson's disease	1.25e-05	3.28e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.24e-05	3.26e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.24e-05	3.26e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.22e-05	3.22e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.17e-05	3.09e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.14e-05	3e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.09e-05	2.87e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.01e-05	2.65e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOE—Parkinson's disease	9.37e-06	2.47e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—INS—Parkinson's disease	8e-06	2.11e-05	CbGpPWpGaD
